{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T10:36:15Z","timestamp":1793097375655,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013410","name":"LivaNova Plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.yebeh.2026.111352","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:32:26Z","timestamp":1792708346000},"page":"111352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expert consensus on the clinical and organizational use of VNS therapy for drug-resistant epilepsy in the United Arab Emirates: a single-round modified Delphi study"],"prefix":"10.1016","volume":"186","author":[{"given":"Abdulla","family":"Alawadhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Al-kaylani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamda","family":"Albastaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Jamil","family":"Asha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Ayman","family":"Haykal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan","family":"Kashyape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulwahab","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaid","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Rumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Di Brino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7513-5706","authenticated-orcid":false,"given":"Taoufik","family":"Alsaadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2026.111352_b0005","series-title":"Epilepsy: a public health imperative","author":"World Health Organization","year":"2019"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111352_b0010","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111352_b0015","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111352_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14581\/jer.19002","article-title":"Antiepileptic Drug Therapy in patients with Drug-Resistant Epilepsy","volume":"9","author":"Park","year":"2019","journal-title":"Journal of epilepsy research"},{"issue":"10","key":"10.1016\/j.yebeh.2026.111352_b0025","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S1474-4422(16)30158-2","article-title":"Sudden unexpected death in epilepsy: epidemiology, mechanisms, and prevention","volume":"15","author":"Devinsky","year":"2016","journal-title":"The Lancet Neurology"},{"issue":"10172","key":"10.1016\/j.yebeh.2026.111352_b0030","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.yebeh.2026.111352_b0035","first-page":"1114","article-title":"Why is there still doubt to cut it out? Epilepsy surgery in the 21st century","volume":"11","author":"Engel","year":"2012","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111352_b0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5698\/1535-7597-13.6.297","article-title":"Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the guideline development subcommittee of the american academy of neurology","volume":"13","author":"Morris","year":"2013","journal-title":"Epilepsy currents"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111352_b0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neubiorev.2005.01.004","article-title":"Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects","volume":"29","author":"Groves","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111352_b0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1528-1157.1994.tb02482.x","article-title":"Vagus nerve stimulation for treatment of partial seizures: 1. a controlled study of effect on seizures","volume":"35","author":"Ben-Menachem","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111352_b0055","doi-asserted-by":"crossref","unstructured":"Morris, G. L., Mueller, W. M., & the Vagus Nerve Stimulation Study Group (1999). Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology, 53(8), 1731\u20131735. doi: 10.1212\/WNL.53.8.1731.","DOI":"10.1212\/WNL.53.8.1731"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111352_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1227\/NEU.0000000000001165","article-title":"Rates and predictors of seizure freedom with vagus nerve stimulation for intractable epilepsy","volume":"79","author":"Englot","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.yebeh.2026.111352_b0065","doi-asserted-by":"crossref","unstructured":"Sen, A., Verner, R., Valeriano, J. P., Lee, R., Zafar, M., Thomas, R., Kotulska, K., Jespers, E., Dibu\u00e9, M., Kwan, P., & CORE-VNS Registry Group (2021). Vagus nerve stimulation therapy in people with drug-resistant epilepsy (CORE-VNS): rationale and design of a real-world post-market comprehensive outcomes registry.BMJ neurology open,3(2), e000218. doi: 10.1136\/bmjno-2021-000218.","DOI":"10.1136\/bmjno-2021-000218"},{"key":"10.1016\/j.yebeh.2026.111352_b0070","doi-asserted-by":"crossref","unstructured":"Kwan, P., Boffini, M., Fahoum, F., El Tahry, R., O'Brien, T. J., Keough, K., Boggs, J., Goldberg-Stern, H., Beraldi, F., Giannicola, G., Lee, Y. C., Sen, A., & CORE\u2010VNS Registry Group (2024). Baseline characteristics and predictors for early implantation of vagus nerve stimulation therapy in people with drug-resistant epilepsy: Observations from an international prospective outcomes registry (CORE-VNS).Epilepsia open,9(5), 1837\u20131846. doi: 10.1002\/epi4.13015.","DOI":"10.1002\/epi4.13015"},{"key":"10.1016\/j.yebeh.2026.111352_b0075","doi-asserted-by":"crossref","unstructured":"Suller Marti, A., Verner, R., Keezer, M., Andrade, A., Veilleux, M., Myers, K., Giannicola, G., Nichol, K., G Burneo, J., & CORE\u2010VNS Registry Group (2025). Reduction of generalized tonic-clonic seizures following vagus nerve stimulation therapy: CORE-VNS Study 24-month follow-up.Epilepsia,66(7), 2307\u20132314. doi: 10.1111\/epi.18371.","DOI":"10.1111\/epi.18371"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111352_b0080","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/epi4.70281","article-title":"Effectiveness and safety of implantable vagus nerve stimulation in people with primary generalized tonic-clonic seizures","volume":"11","author":"Eggleston","year":"2026","journal-title":"Epilepsia open"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111352_b0085","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/epi.18289","article-title":"Vagus nerve stimulation in Lennox-Gastaut syndrome: Twenty-four-month data and experience from the CORE-VNS study","volume":"66","author":"Lyons","year":"2025","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111352_b0090","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.brs.2022.05.016","article-title":"VNS parameters for clinical response in Epilepsy","volume":"15","author":"Fahoum","year":"2022","journal-title":"Brain Stimul"},{"key":"10.1016\/j.yebeh.2026.111352_b0095","doi-asserted-by":"crossref","unstructured":"Bagi\u0107, A. I., Verner, R., Afra, P., Benbadis, S., & ASCEND Study Group (2023). ASCEND: A randomized controlled trial of titration strategies for vagus nerve stimulation in drug-resistant epilepsy.Epilepsy & behavior : E&B,145, 109333. doi: 10.1016\/j.yebeh.2023.109333.","DOI":"10.1016\/j.yebeh.2023.109333"},{"key":"10.1016\/j.yebeh.2026.111352_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108861","article-title":"Rapid titration of VNS therapy reduces time-to-response in epilepsy","volume":"134","author":"Tzadok","year":"2022","journal-title":"Epilepsy & behavior : E&B"},{"key":"10.1016\/j.yebeh.2026.111352_b0105","article-title":"Practical Considerations for the rapid titration of VNS","volume":"29","author":"Tahry","year":"2024","journal-title":"Epilepsy & behavior reports"},{"key":"10.1016\/j.yebeh.2026.111352_b0110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.seizure.2015.08.011","article-title":"A prospective, multicenter study of cardiac-based seizure detection to activate vagus nerve stimulation","volume":"32","author":"Boon","year":"2015","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2026.111352_b0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yebeh.2011.07.020","article-title":"Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy","volume":"22","author":"Helmers","year":"2011","journal-title":"Epilepsy & behavior : E&B"},{"key":"10.1016\/j.yebeh.2026.111352_b0120","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.seizure.2025.08.014","article-title":"Programming in Vagus nerve stimulation therapy: Consensus from a Nordic Delphi Panel","volume":"131","author":"Henning","year":"2025","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2026.111352_b0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.seizure.2024.10.013","article-title":"Expert opinion on use of vagus nerve stimulation therapy in the management of pediatric epilepsy: a Delphi consensus study","volume":"123","author":"Wheless","year":"2024","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111352_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi","volume":"21","author":"Gattrell","year":"2024","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.yebeh.2026.111352_b0135","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/0269216317690685","article-title":"Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review","volume":"31","author":"J\u00fcnger","year":"2017","journal-title":"Palliat Med"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111352_b0140","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.brs.2025.06.016","article-title":"Turning up the current - optimizing stimulation parameters with vagus nerve stimulation in a nationwide norwegian cohort (the NOR-current study)","volume":"18","author":"Kostov","year":"2025","journal-title":"Brain Stimul"},{"issue":"5","key":"10.1016\/j.yebeh.2026.111352_b0145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-0404.2012.01656.x","article-title":"Application of a computational model of vagus nerve stimulation","volume":"126","author":"Helmers","year":"2012","journal-title":"Acta Neurol Scand"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T10:18:50Z","timestamp":1793096330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026004737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":29,"alternative-id":["S1525505026004737"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111352","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert consensus on the clinical and organizational use of VNS therapy for drug-resistant epilepsy in the United Arab Emirates: a single-round modified Delphi study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111352"}}